TRV GP Iv, LLC, 10% Owner at Magenta Therapeutics, Inc. (MGTA), sold 3,700,000 shares at $0.83 ($3.1M) on 2023-02-07, disclosed to the SEC on 2023-02-09.
Open-market sale of $3.1M MGTA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.83 | 2,200,000 | $1.8M | 59.8% |
| 2 | $0.82 | 1,500,000 | $1.2M | 40.2% |
| Total | $0.83 avg | 3,700,000 | $3.1M | 100% |
| Filing → |
| TNGX | SELL | 2025-09-17 | $5.1M | — | Filing → |
| TNGX | SELL | 2025-09-09 | $5.7M | — | Filing → |
| TNGX | SELL | 2024-09-17 | $710K | — | Filing → |